TBG Diagnostics Health Care
Asia Biotech Healthcare Medical Pharmaceuticals

$0.270 (0%)

High -	Low -	Trades -	Turnover $0	Volume 0
5 August 2026 at 8:45am

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code TDL	Name TBG Diagnostics Limited	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Pharmaceuticals, Biotechnology & Life Sciences	GIC Industry Biotechnology	GIC Sub Industry Biotechnology
Sector Healthcare	IPO Date N/A	Fiscal Year December	Type Common Stock
Shares Outstanding 217,587,008	Shares Floated 47,444,908	Held by Insiders 74.627%	Held by Institutions 0.001%

Directors & Officers

Name & Education	Position
Mr. Indrajit Solomon Arulampalam	Exec. Chairman
Ms. Generosa Hipona	CFO & GM of Fin.
Mr. Justyn Peter Stedwell B.Com, B.Com.	Company Sec.
Mr. Willy M. Hsu	Chief Operating Officer
Dr. Michael Chen	Chief Scientific Officer
Dr. Edward Hammond	Head of Biology
Dr. Paul Handley	Head of Chemistry
Dr. Tomislav Karoli	Head of Process Chemistry
Mr. Ifan Chiu	Pres of TBG (Xiamen) Inc

TDL Historic Dividends

Date	Amount
We found no dividends on record for TDL.

End of Day Prices

Date	Close	Volume	Change
30-Aug	$0.27	0	0.00 (0.00%)
27-Aug	$0.27	0	0.00 (0.00%)
26-Aug	$0.27	0	0.00 (0.00%)
25-Aug	$0.27	0	0.00 (0.00%)
24-Aug	$0.27	0	0.00 (0.00%)
23-Aug	$0.27	0	0.00 (0.00%)
20-Aug	$0.27	0	0.00 (0.00%)
19-Aug	$0.27	0	0.00 (0.00%)
18-Aug	$0.27	0	0.00 (0.00%)
17-Aug	$0.27	0	0.00 (0.00%)
16-Aug	$0.27	0	0.00 (0.00%)
13-Aug	$0.27	0	0.00 (0.00%)
12-Aug	$0.27	0	0.00 (0.00%)
11-Aug	$0.27	0	0.00 (0.00%)
10-Aug	$0.27	0	0.00 (0.00%)
0 up, 0 down, and 15 flat days

Market Cap (30-Aug) $58,748,496	EBITDA -	PE 0.00	Book Value $0.03
Dividend per Share N/A	Dividend Yield 0%	EPS $-0.02	Profit Margin N/A
Operating Margin -74.24%	ROA 14.28%	ROE 38.05%	Revenue (FY) $4,605,983
Revenue per Share $0.02	Gross Profit (FY) $2,657,076	Q' YOY Revenue Growth 22.9%	Q' YOY Earnings Growth -

TBG Diagnostics Health Care
Asia Biotech Healthcare Medical Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (December 2020)

Directors & Officers

TDL Historic Dividends

Followers

Prices

Announcements

End of Day Prices

TBG Diagnostics Health Care Asia Biotech Healthcare Medical Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (December 2020)

Directors & Officers

TDL Historic Dividends

Followers

Prices

Announcements

End of Day Prices

TBG Diagnostics Health Care
Asia Biotech Healthcare Medical Pharmaceuticals